Our review entitled ” High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer” (Bottger et al., J Exp Clin Cancer Res. 2021 Oct 30;40(1):343) is getting attention. Not only in PubMed but now also via a Podcast in the series Decoding Health Care Research. Watch on youtube: https://youtu.be/eDUWWOkY4S0?si=8O8Ffxrw8PEdnXW6
Read More
Celebration of next generation mass spectrometry in the Proteomics Core Facility Venue: Auditorium O2 building Date: 14.00- 17.30, 23 Jan. 2023 Program 14.00- 14.15 Inloop (koffie / thee) 14.15-14.20 Welcome (Connie Jimenez, director Proteomics Core Resource) 14.20-14.30 (Phospho)proteomics highlights of the past decade (Connie) Collaborator orals 14.30-14.45 Proteomics to study […]
Read More
Core question: Can we identify predictive protein biomarkers for the selection of patients benefiting from platinum-based adjuvant chemotherapy (ACT) in non-small cell lung cancer (NSCLC)? Core insight: Our study published Nov 27th in Molecular Oncology presents the discovery of predictive biomarkers that can aid in distinguishing patients with NSCLC likely to derive clinical benefit from […]
Read More